Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PJ 009

Next Previous
X
Search
Drug Profile

PJ 009

Alternative Names: Glucagon-Like Peptide 2 (GLP-2) analogue; PJ-009

Latest Information Update: 02 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chongqing Peg-Bio Biopharm
  • Class Anti-inflammatories; Glucagon-like peptides; Peptides
  • Mechanism of Action Glucagon-like peptide 2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Short bowel syndrome

Most Recent Events

  • 26 Jul 2024 Phase-III clinical trials in Short bowel syndrome (In adults, In the elderly, In adolescents) in China (SC) (NCT06512584)
  • 15 May 2023 Chongqing Peg-Bio Biopharm completes a phase I trial in Short bowel syndrome (In volunteers, In adults) in China (SC) (NCT06523101)
  • 28 Feb 2023 Phase-I clinical trials in Short bowel syndrome (In volunteers, In adults) in China (SC) (NCT06523101)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top